0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Head and Neck cancer (HNC) -Epidemiology Forecast to 2028
Published Date: March 2019
|
Report Code: DELV-Epid-126
Home | Category |Health |Health Conditions |Cancer
Head and Neck cancer Epidemiology Forecast to 2028

Head and Neck cancer (HNC) -Epidemiology Forecast to 2028

Code: DELV-Epid-126
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight's "Head and Neck cancer (HNC) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Head and Neck cancer (HNC) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Head and Neck cancer (HNC) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Head and Neck cancer (HNC) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Head and Neck cancer (HNC) outlook. It also includes the explanation of changing trends of epidemiology outlining the Head and Neck cancer (HNC) scenario.

Head and Neck cancer (HNC) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Head and Neck cancer (HNC) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Head and Neck cancer (HNC) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Head and Neck cancer (HNC) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Head and Neck cancer (HNC)

Key assessments
• Patient Segmentation in Head and Neck cancer (HNC)
• Head and Neck cancer (HNC) Risk & Burden
• Factors driving growth in a specific Head and Neck cancer (HNC) patient population

1. Report Introduction
2. Head and Neck cancer (HNC) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Head and Neck cancer (HNC) in 2016
2.2. Patient Share Distribution of Head and Neck cancer (HNC) in 2028
3. Disease Background and Overview: Head and Neck cancer (HNC)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Head and Neck cancer (HNC) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Head and Neck cancer (HNC) in 7MM – By Countries
5. Epidemiology of Head and Neck cancer (HNC) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.1.3. Sub-Type Specific cases of the Head and Neck cancer (HNC) *
5.1.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.1.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.4.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.4.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.4.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.5.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.5.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.5.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.6.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.6.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.6.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.7.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.7.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.7.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.8.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.8.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.8.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.9.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.9.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.9.5. Diagnosed Cases of the Head and Neck cancer (HNC)
6. Unmet Needs of the Head and Neck cancer (HNC)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

 

List of Tables

Table 1: Total Prevalent/Incident Cases of the Head and Neck cancer (HNC) in 7MM
Table 2: Total Prevalent/Incident Cases of the Head and Neck cancer (HNC) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Head and Neck cancer (HNC) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Head and Neck cancer (HNC) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Head and Neck cancer (HNC) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Head and Neck cancer (HNC) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Head and Neck cancer (HNC) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Head and Neck cancer (HNC) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Head and Neck cancer (HNC) in France (2016-2028) *
Table 14: Diagnosed Cases of the Head and Neck cancer (HNC) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Head and Neck cancer (HNC) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Head and Neck cancer (HNC) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Head and Neck cancer (HNC) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Head and Neck cancer (HNC) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Head and Neck cancer (HNC) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Head and Neck cancer (HNC) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Head and Neck cancer (HNC) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Head and Neck cancer (HNC) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Head and Neck cancer (HNC) in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Head and Neck cancer (HNC) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Head and Neck cancer (HNC) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Head and Neck cancer (HNC) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Head and Neck cancer (HNC) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Head and Neck cancer (HNC) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Head and Neck cancer (HNC) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Head and Neck cancer (HNC) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Head and Neck cancer (HNC) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Head and Neck cancer (HNC) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Head and Neck cancer (HNC) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Head and Neck cancer (HNC) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Head and Neck cancer (HNC) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Head and Neck cancer (HNC) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Head and Neck cancer (HNC) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Head and Neck cancer (HNC) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Head and Neck cancer (HNC) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Head and Neck cancer (HNC) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Head and Neck cancer (HNC) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Head and Neck cancer (HNC) in Japan (2016-2028)

DelveInsight's "Head and Neck cancer (HNC) - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Head and Neck cancer (HNC) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2028

Head and Neck cancer (HNC) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Head and Neck cancer (HNC) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Head and Neck cancer (HNC) outlook. It also includes the explanation of changing trends of epidemiology outlining the Head and Neck cancer (HNC) scenario.

Head and Neck cancer (HNC) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Head and Neck cancer (HNC) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Head and Neck cancer (HNC) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Head and Neck cancer (HNC) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Head and Neck cancer (HNC)

Key assessments
• Patient Segmentation in Head and Neck cancer (HNC)
• Head and Neck cancer (HNC) Risk & Burden
• Factors driving growth in a specific Head and Neck cancer (HNC) patient population

Read More

1. Report Introduction
2. Head and Neck cancer (HNC) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Head and Neck cancer (HNC) in 2016
2.2. Patient Share Distribution of Head and Neck cancer (HNC) in 2028
3. Disease Background and Overview: Head and Neck cancer (HNC)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Head and Neck cancer (HNC) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Head and Neck cancer (HNC) in 7MM – By Countries
5. Epidemiology of Head and Neck cancer (HNC) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.1.3. Sub-Type Specific cases of the Head and Neck cancer (HNC) *
5.1.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.1.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.4.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.4.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.4.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.5.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.5.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.5.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.6.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.6.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.6.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.7.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.7.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.7.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.8.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.8.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.8.5. Diagnosed Cases of the Head and Neck cancer (HNC)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Head and Neck cancer (HNC)
5.9.3. Sub-Type Specific cases of the Head and Neck cancer (HNC)*
5.9.4. Sex- Specific Cases of the Head and Neck cancer (HNC)*
5.9.5. Diagnosed Cases of the Head and Neck cancer (HNC)
6. Unmet Needs of the Head and Neck cancer (HNC)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

Read More

 

List of Tables

Table 1: Total Prevalent/Incident Cases of the Head and Neck cancer (HNC) in 7MM
Table 2: Total Prevalent/Incident Cases of the Head and Neck cancer (HNC) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Head and Neck cancer (HNC) in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Head and Neck cancer (HNC) in United States (2016-2028)*
Table 6: Diagnosed Cases of the Head and Neck cancer (HNC) in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Head and Neck cancer (HNC) in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Head and Neck cancer (HNC) in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in France (2016-2028)
Table 12: Sub-Type Specific cases of the Head and Neck cancer (HNC) in France (2016-2028) *
Table 13: Sex- Specific Cases of the Head and Neck cancer (HNC) in France (2016-2028) *
Table 14: Diagnosed Cases of the Head and Neck cancer (HNC) in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Head and Neck cancer (HNC) in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Head and Neck cancer (HNC) in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Head and Neck cancer (HNC) in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Head and Neck cancer (HNC) in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Head and Neck cancer (HNC) in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Head and Neck cancer (HNC) in UK (2016-2028) *
Table 26: Diagnosed Cases of the Head and Neck cancer (HNC) in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Head and Neck cancer (HNC) in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Head and Neck cancer (HNC) in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Head and Neck cancer (HNC) in 7MM
Figure 2: Total Prevalent/Incident Cases of the Head and Neck cancer (HNC) in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Head and Neck cancer (HNC) in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Head and Neck cancer (HNC) in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Head and Neck cancer (HNC) in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Head and Neck cancer (HNC) in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Head and Neck cancer (HNC) in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Head and Neck cancer (HNC) in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Head and Neck cancer (HNC) in France (2016-2028) *
Figure 14: Diagnosed Cases of the Head and Neck cancer (HNC) in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Head and Neck cancer (HNC) in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Head and Neck cancer (HNC) in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Head and Neck cancer (HNC) in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Head and Neck cancer (HNC) in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Head and Neck cancer (HNC) in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Head and Neck cancer (HNC) in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Head and Neck cancer (HNC) in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Head and Neck cancer (HNC) in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Head and Neck cancer (HNC) in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Head and Neck cancer (HNC) in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Head and Neck cancer (HNC) in Japan (2016-2028)

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3250
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$6500
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$9750
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension
0 Items
X
No items in the cart.
$0.0